{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "The confusing tangle of information found on the labels of prescription drugs will soon undergo a major revision, a move federal drug regulators hope will reduce the injuries and deaths caused by medical errors. The changes, announced Wednesday by the Food and Drug Administration, are intended to clarify the flood of information that doctors routinely confront when assessing the safety of prescription drugs. The new rule does not affect the drug information sheets that patients routinely receive, but is likely to result in major changes to drug advertisements and may offer some liability protections to drug makers.", "headline": {"main": "New Drug Label Rule Is Intended to Reduce Medical Errors"}, "abstract": null, "print_page": "20", "word_count": 1002, "_id": "4fd24fd48eb7c8105d7f2b77", "snippet": "The changes are intended to clarify the flood of information that doctors routinely confront when assessing the safety of prescription drugs.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2006/01/19/national/19label.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Gardiner", "rank": 1, "lastname": "HARRIS"}], "original": "By GARDINER HARRIS"}, "document_type": "article", "pub_date": "2006-01-19T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "An Analysis; News Analysis", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Just 30 terminally ill people exercise a right each year that is unique in America to the state of Oregon, hastening their deaths with a lethal dose of drugs prescribed by doctors. The Supreme Court decision on Tuesday rejecting the Justice Department's effort to block the state's Death With Dignity Act will allow such suicides to continue, but it may not have the broad impact people on both sides of the debate are predicting.", "headline": {"main": "Fraught Issue, but Narrow Ruling in Oregon Suicide Case", "kicker": "News Analysis"}, "abstract": null, "print_page": "16", "word_count": 1168, "_id": "4fd2873f8eb7c8105d858f2f", "snippet": "The Supreme Court's upholding of assisted-suicide may not have the broad impact that some people are predicting.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2006/01/18/national/18oregon.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "OREGON"}, {"name": "subject", "value": "DEATH AND DYING"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Timothy", "rank": 1, "lastname": "EGAN"}, {"organization": "", "role": "reported", "firstname": "Adam", "rank": 2, "lastname": "LIPTAK"}], "original": "By TIMOTHY EGAN and ADAM LIPTAK; Timothy Egan reported from Portland for this article, and Adam Liptak from New York"}, "document_type": "article", "pub_date": "2006-01-18T00:00:00Z", "section_name": "U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "The Bush administration said Tuesday that more than 2.6 million people had voluntarily signed up for Medicare's prescription drug benefit in the last 30 days, pushing the total voluntary enrollment to 3.6 million. Michael O. Leavitt, the secretary of health and human services, cautioned beneficiaries that they might still encounter problems when they tried to use the new benefit for the first time.", "headline": {"main": "Rolls Growing For Drug Plan As Problems Continue"}, "abstract": null, "print_page": "17", "word_count": 674, "_id": "4fd24e7a8eb7c8105d7f0644", "snippet": "The Bush administration said that more than 2.6 million people had signed up for Medicare's prescription drug benefit in the last 30 days.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2006/01/18/national/18medicare.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Robert", "rank": 1, "lastname": "PEAR"}], "original": "By ROBERT PEAR"}, "document_type": "article", "pub_date": "2006-01-18T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Two new approaches to weight loss are up for review by federal regulators. And they represent vastly different solutions to the nation's obesity epidemic -- for consumers and for the companies behind the drugs. One, called Acomplia, would be a prescription pill to control appetite by blocking the same brain receptors that stimulate the ''munchies'' in marijuana smokers. Some financial analysts see Acomplia as the most promising new drug of the year, and they predict multibillion-dollar sales eventually for its maker, the French company Sanofi-Aventis.", "headline": {"main": "2 Approaches to the Nation's Obesity Epidemic Coming Up for Review"}, "abstract": null, "print_page": "1", "word_count": 1590, "_id": "4fd2aa078eb7c8105d895ec8", "snippet": "Two new approaches to weight loss are up for review by federal regulators. And they represent vastly different solutions to the nation's obesity epidemic -- for consumers and for the companies behind the drugs.     One, called Acomplia, would be a...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9403EFDA143FF934A25752C0A9609C8B63", "multimedia": [], "subsection_name": null, "keywords": [], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Stephanie", "rank": 1, "lastname": "SAUL"}], "original": "By STEPHANIE SAUL"}, "document_type": "article", "pub_date": "2006-01-17T00:00:00Z", "section_name": "Business"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Scientists have discovered a variant gene that leads to a sizable extra risk of Type 2 diabetes and is carried by more than a third of the American population. The finding is being reported today in the journal Nature Genetics by researchers at Decode Genetics, a company in Reykjavik, Iceland, that specializes in finding the genetic roots of human diseases. Decode Genetics first found the variant gene -- one of many different versions that exist in the human population -- in Icelanders and has now confirmed the finding in a Danish and an American population.", "headline": {"main": "Gene Increases Diabetes Risk, Scientists Find"}, "abstract": null, "print_page": "1", "word_count": 760, "_id": "4fd2aa078eb7c8105d895eb4", "snippet": "The variant gene leads to a sizable extra risk of Type 2 diabetes and is carried by more than a third of the American population.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2006/01/16/science/16gene.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "DIABETES"}, {"name": "subject", "value": "GENETICS AND HEREDITY"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Nicholas", "rank": 1, "lastname": "WADE"}], "original": "By NICHOLAS WADE"}, "document_type": "article", "pub_date": "2006-01-16T00:00:00Z", "section_name": "Front Page; Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "The drug cart rolls along the corridors of the Sarah Neuman Center for Healthcare and Rehabilitation here, dispensing medication to 244 nursing home residents. Coumadin for blood clots. Motrin for arthritis pain. Serzone for depression. Vasotec for high blood pressure. Aricept for Alzheimer's disease. The nation's frailest elderly take an average of seven medications a day, a financial burden on individuals, families, institutions and state treasuries that inspired the Medicare prescription drug plan, which took effect on Jan. 1 and is available to 42 million Americans over the age of 65.", "headline": {"main": "Nursing Homes Confront New Drug Plan's Hurdles"}, "abstract": "Nursing homes are first largescale testing grounds for new Medicare prescription drug plan's bureaucracy; residents continue to get medications, but nursing home staffs are in tumult as they try to make sense of 43 different drug plans, which are subsidized by government but administered by private companies; months of preparation have been all but useless; New England Journal of Medicine speculates that nursing home patients already on Medicaid may be worse off due to plan; photos (M)", "print_page": "16", "word_count": 1367, "_id": "4fd24e798eb7c8105d7f05ce", "snippet": "At nursing homes, the elderly get their medication but those running the homes struggle to make sense of the Medicare drug plan.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2006/01/15/national/15nurse.html", "multimedia": [{"url": "images/2006/01/15/national/15nurse75.jpg", "subtype": "thumbnail", "legacy": {"hasthumbnail": "Y", "thumbnailheight": 75, "thumbnail": "images/2006/01/15/national/15nurse75.jpg"}, "type": "image", "height": 75}], "subsection_name": null, "keywords": [{"name": "organizations", "value": "NEW ENGLAND JOURNAL OF MEDICINE"}, {"name": "subject", "value": "HEALTH INSURANCE AND MANAGED CARE"}, {"name": "subject", "value": "BUREAUCRATIC RED TAPE"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "MEDICAID"}, {"name": "subject", "value": "AGED"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "TESTS AND TESTING"}, {"name": "subject", "value": "NURSING HOMES"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Jane", "rank": 1, "lastname": "GROSS"}], "original": "By JANE GROSS"}, "document_type": "article", "pub_date": "2006-01-15T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Metropolitan Desk", "lead_paragraph": "Gov. George E. Pataki has a plan to eliminate the state's $2 billion surplus. And then some. But as the governor prepares to unveil his 12th and final budget proposal on Tuesday, many lawmakers are asking whether he will offer a plan meant to score political points on a national stage or to provide a sound blueprint for managing New York.", "headline": {"main": "In Final Term, Pataki to Offer A State Budget That Cuts Taxes"}, "abstract": null, "print_page": "25", "word_count": 1264, "_id": "4fd24e798eb7c8105d7f05dc", "snippet": "Many lawmakers are asking if Gov. George E. Pataki will offer a plan meant to score political points nationwide or to provide a sound blueprint for managing New York.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2006/01/15/nyregion/15budget.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "PATAKI, GEORGE E"}, {"name": "subject", "value": "BUDGETS AND BUDGETING"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Danny", "rank": 1, "lastname": "HAKIM"}], "original": "By DANNY HAKIM"}, "document_type": "article", "pub_date": "2006-01-15T00:00:00Z", "section_name": "New York and Region"}, {"type_of_material": "News", "blog": [], "news_desk": "Week in Review Desk", "lead_paragraph": "IT'S sick, the way Americans think about illness. A disease like diabetes gallops practically out of control, with estimates that 21 million Americans have it and 45 million more could develop it. Yet relatively few people worry about it or alter their behavior to postpone or possibly prevent its onset.", "headline": {"main": "On Not Wanting to Know What Hurts You", "kicker": "IDEAS & TRENDS"}, "abstract": null, "print_page": "14", "word_count": 850, "_id": "4fd24e798eb7c8105d7f05c9", "snippet": "A disease like diabetes gallops practically out of control, yet relatively few people worry about it or alter their behavior to postpone or possibly prevent its onset.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2006/01/15/weekinreview/15fount.html", "multimedia": [{"url": "images/2006/01/15/weekinreview/15fountain.75.jpg", "subtype": "thumbnail", "legacy": {"hasthumbnail": "Y", "thumbnailheight": 75, "thumbnail": "images/2006/01/15/weekinreview/15fountain.75.jpg"}, "type": "image", "height": 75}], "subsection_name": null, "keywords": [{"name": "subject", "value": "DIET AND NUTRITION"}, {"name": "subject", "value": "DIABETES"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Henry", "rank": 1, "lastname": "FOUNTAIN"}], "original": "By HENRY FOUNTAIN"}, "document_type": "article", "pub_date": "2006-01-15T00:00:00Z", "section_name": "Health; Week in Review"}], "meta": {"hits": 8, "offset": 0, "time": 49}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}